University of Vermont

From the Land of Bernie Sanders: Vermont’s Newest Medical Students Weigh in on Single-Payer

21-Oct-2015 11:05 AM EDT, by University of Vermont

Newswise — In Bernie Sanders’ home state of Vermont, the newest class of medical students will be participating in a major career milestone – the White Coat Ceremony – on Friday, October 23, 2015. As future physicians, they see a strong need to change the system, but recognize the challenges to actualizing that goal. “Single payer would be a better system and there are similar systems succeeding in other countries, but it requires everyone’s buy-in for it to work, which clearly isn’t the case right now in America,” says Williston, Vt., native F. Gregory Gause of the University of Vermont College of Medicine’s Class of 2019. “When Vermont tried to unilaterally go to a single-payer system, we were not able to create a more efficient system.”

“As a future physician, I would value practicing in an environment where equal and uninhibited access to care is of paramount importance and doctors are reimbursed in a logical manner,” says Allison Greene, a native of Essex Junction, Vt. “The Patient Protection and Affordable Care Act was a step in the right direction in terms of expanding health insurance coverage and reducing costs, but it seems to have done little to alleviate the administrative burden of signing up for coverage or streamline reimbursement rates for hospitals and clinics. A single-payer system is far simpler, more equitable, and, as has been demonstrated in other countries, produces better health outcomes.”

A native of Sander’s hometown – Burlington, Vt. – Callie Krumholz Linehan says “I support single-payer healthcare, and believe that all people deserve equal access to care. I will advocate for my patients and my community during all of the many changes to the healthcare landscape over the course of my career.”

Prior to medical school, Gause played basketball for Montreal’s McGill University, where he majored in anatomy and cell biology before returning to Vermont and working as a medical assistant in dermatology at the UVM Medical Center. Greene worked as a medical assistant and rescue squad member, and volunteered at a rural health clinic in California before medical school. Linehan majored in biology at Utica, N.Y.-based Hamilton College and worked briefly with children with Asperger’s syndrome, then moved to Seattle and conducted ovarian cancer research at the Fred Hutchinson Cancer Research Center before returning home.

There are 116 students in the UVM College of Medicine’s Class of 2019. Roughly 30 percent of each class of UVM’s medical students hail from the Green Mountain State.

Filters close

Showing results

110 of 4573
Released: 15-Jan-2021 5:40 PM EST
Research Links Social Isolation to COVID-19 Protocol Resistance
Humboldt State University

As health officials continue to implore the public to wear masks and practice social distancing, recent research by Humboldt State University Psychology Professor Amber Gaffney provides key insights into connections between social isolation, conspiratorial thinking, and resistance to COVID-19 protocols.

Newswise: Rapid blood test identifies COVID-19 patients at high risk of severe disease
Released: 15-Jan-2021 5:35 PM EST
Rapid blood test identifies COVID-19 patients at high risk of severe disease
Washington University in St. Louis

Scientists at Washington University School of Medicine in St. Louis have shown that a relatively simple and rapid blood test can predict which patients with COVID-19 are at highest risk of severe complications or death. The blood test measures levels of mitochondrial DNA, which normally resides inside the energy factories of cells. Mitochondrial DNA spilling out of cells and into the bloodstream is a sign that a particular type of violent cell death is taking place in the body.

Released: 15-Jan-2021 2:55 PM EST
COVID-19 deaths really are different. But best practices for ICU care should still apply, studies suggest.
Michigan Medicine - University of Michigan

COVID-19 deaths are indeed different from other lung failure deaths, according to two recent studies, with 56% of COVID-19 patients dying primarily from the lung damage caused by the virus, compared with 22% of those whose lungs fail due to other causes. But, the researchers conclude, the kind of care needed to help sustain people through the worst cases of all forms of lung failure is highly similar, and just needs to be fine-tuned.

Released: 15-Jan-2021 2:50 PM EST
45% of adults over 65 lack online medical accounts that could help them sign up for COVID-19 vaccinations
Michigan Medicine - University of Michigan

As the vaccination of older adults against COVID-19 begins across the country, new poll data suggests that many of them don’t yet have access to the “patient portal” online systems that could make it much easier for them to schedule a vaccination appointment. In all, 45% of adults aged 65 to 80 had not set up an account with their health provider’s portal system.

Released: 15-Jan-2021 1:30 PM EST
New England Journal of Medicine publishes COVID-19 treatment trial results
University of Texas at San Antonio

A clinical trial involving COVID-19 patients hospitalized at UT Health San Antonio and University Health, among roughly 100 sites globally, found that a combination of the drugs baricitinib and remdesivir reduced time to recovery, according to results published Dec. 11 in the New England Journal of Medicine.

Released: 15-Jan-2021 12:40 PM EST
DNA test can quickly identify pneumonia in patients with severe COVID-19, aiding faster treatment
University of Cambridge

Researchers have developed a DNA test to quickly identify secondary infections in COVID-19 patients, who have double the risk of developing pneumonia while on ventilation than non-COVID-19 patients.

Released: 15-Jan-2021 12:30 PM EST
Fight CRC To Present Research Findings on The Impact of COVID-19 on the Colorectal Cancer Community at 2021 GI ASCO
Fight Colorectal Cancer

Fight Colorectal Cancer presents abstract at Gastrointestinal Cancer Symposium highlighting the need to address the barriers and opportunities for care within the colorectal cancer community during the COVID-19 pandemic

Released: 15-Jan-2021 12:25 PM EST
Technion to Award Honorary Doctorate to Pfizer CEO Dr. Albert Bourla
American Technion Society

Israel's Technion will award an honorary doctorate to Pfizer CEO and Chairman Dr. Albert Bourla, for leading the development of the novel vaccine against SARS-CoV-2, the virus that causes COVID-19. The honorary doctorate will be conferred at the Technion Board of Governors meeting in November 2021.

Released: 15-Jan-2021 11:30 AM EST
UW researchers develop tool to equitably distribute limited vaccines
University of Wisconsin-Madison

Researchers at the University of Wisconsin School of Medicine and Public Health and UW Health have developed a tool that incorporates a person’s age and socioeconomic status to prioritize vaccine distribution among people who otherwise share similar risks due to their jobs.

Showing results

110 of 4573